openPR Logo
Press release

Global Rheumatology Therapeutics Market poised to grow at a CAGR of 2.52 % by 2024: Infinium Global Research

02-20-2018 11:49 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Infinium Global Research

Infinium Global Research

Infinium Global Research

The report on Rheumatology Therapeutics Market by Drug Class (disease modifying anti-rheumatic, nonsteroidal anti-inflammatory, corticosteroids, uric acid drugs), by Disease Indication (rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, ankylosing spondylitis), and by Distribution Channel (hospital, retail, online pharmacy) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Rheumatology Therapeutics Market is projected to grow at a CAGR of 2.52% in terms of value over the period of 2018-2024.

Get 15% discount for Global rheumatology therapeutics Market: https://www.infiniumglobalresearch.com/Reports/requestdiscount/1129

The recent report on global rheumatology therapeutics market identified that North America dominated the global rheumatology therapeutics market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the rheumatology therapeutics Market worldwide. Increasing incidences of rheumatic arthritis in North America and Europe owing to rising pool of geriatric population is a primary factor driving the growth in the world market. Furthermore, growing per capita healthcare expenditure coupled with rising number of patients over 50 years of age are likely to offer susbtantail growth opportunities in the Asia-Pacific region, as a result the Asia-Pacific rhematology therapeutics market is expected to grow at the highest CAGR over the forecast period-identifies Infinium Global Research.

Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global rheumatology therapeutics market but also make strategic decisions to capture the most lucrative markets in the near future.

The market size is presented in terms of value for the historic year 2016 and estimated for forecast period of 2018 to 2024.The report segments the global rheumatology therapeutics market on the basis of drug class, disease indication, and distribution channel.

Get Free Sample Pages of this Report: https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/1129

Global Rheumatology Therapeutics Market by Drug Class
• Disease Modifying Anti-rheumatic Drugs
• Nonsteroidal Anti-inflammatory Drugs
• Corticosteroids
• Uric Acid Drugs
• Others

Global Rheumatology Therapeutics Market by Disease Indication
• Rheumatoid Arthritis
• Osteoarthritis
• Gout
• Gout
• Ankylosing Spondylitis
• Others

Global Rheumatology Therapeutics Market by Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Rheumatology Therapeutics Market by Regions
• North America
• Europe
• Asia-Pacific
• RoW

Companies Profiled in the report
• Takeda Pharmaceutical
• Sanofi
• Genentech, Inc.
• Novartis AG
• Janssen Biotech, Inc.
• Amgen, Inc.
• AbbVie, Inc.
• Pfizer, Inc.
• Bristol-Myers Squibb Company
• Merck & Co., Inc

Browse Complete TOC of this Report: https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_rheumatology_therapeutics_market

About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

About Us:

Infinium Global Research and Consulting Solutions is started with a single motto of being business partner of first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you.

Contact Us:

Infinium Global Research
Goyal Shinde Park, Bhau Patil Road,
Bopodi, Pune-411 020.
U.S. + Canada Toll Free: 1-800-638-0796
Email: sales@infiniumglobalresearch.com
Website: https://www.infiniumglobalresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Rheumatology Therapeutics Market poised to grow at a CAGR of 2.52 % by 2024: Infinium Global Research here

News-ID: 950000 • Views:

More Releases from Infinium Global Research

Bio-Based Construction Polymers Market Analysis: USD 17.32 Billion Valuation in 2023 to USD 25.30 Billion by 2032 at 4.40% CAGR
Bio-Based Construction Polymers Market Analysis: USD 17.32 Billion Valuation in …
The bio-based construction polymers market has emerged as a critical component of the global shift toward sustainable construction materials. In 2023, the market reached USD 17.32 billion and is projected to hit USD 25.30 billion by 2032, driven by a CAGR of 4.40%. This steady expansion reflects the rising demand for renewable materials capable of reducing carbon footprints and supporting climate-conscious building practices. Increasing regulatory pressure on the construction sector,
Global Cake Mixes Market to Reach USD 2.31 Billion by 2032 | Steady 4.85% CAGR Driven by Convenience Baking Trends
Global Cake Mixes Market to Reach USD 2.31 Billion by 2032 | Steady 4.85% CAGR D …
The global cake mixes market is witnessing steady expansion as consumers increasingly embrace convenient food solutions that align with fast-paced lifestyles. With the market valued at USD 1532.4 million in 2023 and projected to reach USD 2316.25 million by 2032, the sector continues to evolve through trends such as healthier formulations, clean-label ingredients, and innovative flavors. Rising interest in home baking, amplified by social media, is further propelling demand. As
Global Open Source Services Market Outlook 2024-2032: Growth from USD 27.34 Billion to USD 89.45 Billion at a 13.48% CAGR
Global Open Source Services Market Outlook 2024-2032: Growth from USD 27.34 Bill …
The global open source services market continues to experience robust expansion driven by rising digital transformation and the widespread adoption of open-source technologies across industries. Valued at USD 27.34 billion in 2023, the market is projected to reach USD 89.45 billion by 2032, growing at a CAGR of 13.48%. Organizations are increasingly shifting to open-source ecosystems due to their flexibility, cost advantages, and community-driven innovation. Key growth drivers include the
United States Data Analytics Market is Expected to Reach USD 65.43 Billion in 2032 with a CAGR of 20.5% During the Forecast Period
United States Data Analytics Market is Expected to Reach USD 65.43 Billion in 20 …
The United States data analytics market has emerged as one of the most transformative pillars of the digital economy. Valued at USD 12.22 billion in 2023, the market is projected to reach USD 65.43 billion by 2032, expanding at an impressive 20.5% CAGR from 2024 to 2032. Across industries, organizations are aggressively shifting toward data-driven decision-making, automation, artificial intelligence (AI), and cloud-based analytical platforms that enable real-time insights. This surge

All 5 Releases


More Releases for Rheumatology

Understanding the Rheumatology Market: Segments & Scope
According to The Insight Partners, the rheumatology market is broadly segmented by: • Drug class: nonsteroidal anti inflammatory drugs (NSAIDs), corticosteroids, uric acid drugs, and disease modifying anti rheumatic drugs (DMARDs). • Disease indications: rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, ankylosing spondylitis. • Distribution channels: hospital pharmacies, retail pharmacies, online pharmacies. • Geography: the usual regions (North America, Europe, Asia Pacific, South & Central America, etc.) with further country level breakdowns. CAGR (Compound Annual Growth
Increasing Autoimmune Disease Prevalence Drives Rheumatology Therapeutics Market …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Rheumatology Therapeutics Market Size Growth Forecast: What to Expect by 2025? The market for rheumatology therapeutics has seen robust growth in the recent past. The market size is expected to expand from $42.4 billion in 2024 to $44.61 billion in 2025, marking a compound annual growth rate (CAGR) of
Rheumatology Therapeutics Market to Hit $59.1 Billion by 2030
◉ Global Rheumatology Therapeutics Market Set to Reach USD 59.1 Billion by 2030, Driven by Aging Population and Innovation The global rheumatology therapeutics market is poised for steady growth, projected to reach nearly USD 59.1 billion by 2030, expanding at a CAGR of 2.7% from 2024 to 2030, according to Maximize Market Research. This growth is fueled by an aging global population, rising prevalence of rheumatic diseases, and continuous advancements in
Rheumatology Therapeutics Market 2023 Driving Factors Forecast Research 2029
Rheumatology Therapeutics market is anticipated to grow at a CAGR of 3.2% during the forecast period (2023-2030). Therapeutic drugs are used to slow down the progression of certain autoimmune rheumatic diseases such as rheumatic arthritis (RA). The increasing prevalence of RA globally has bolstered the launch of novel therapeutic agents and favorable refurbishment policies for high-cost treatment products are some of the factors driving the market growth. According to the
Current trends in Rheumatology, Orthopedics, and Arthroplasty
2nd International Conference on Rheumatology, Orthopedics and Arthroplasty December 05-06, 2022 | Dubai, UAE Theme: Current Trends in Rheumatology, Orthopedics and Arthroplasty Rheumatology 2022 will provide an international platform for all Speakers, Delegates, Surgeons, Research Scholars, Orthopedic Physicians, Orthopedic Surgeons, Rheumatologists, Orthopedic and Rheumatology Research Fellows, Orthopedic and Rheumatology Faculty, Directors and Chair Persons, Health Care Professionals, Orthopedic and Rheumatology Medical Students, Orthopedics Medical Colleges, Universities, Orthopedics Devices Designers etc. Audience Profile: ·
Rheumatology Therapeutics Market
Global Rheumatology Therapeutics Market: Snapshot A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market. This has led to the emergence of many new drugs. Their swift approvals by the appropriate authorities has also led to the growth in the market. A report by Transparency Market Research uncovers after in-depth study that the global rheumatology